Supplementary File: Efficacy and safety of lebrikizumab in adolescents with atopic dermatitis over 24 weeks: An analysis from the BIOREP registry
收藏NIAID Data Ecosystem2026-05-10 收录
官方服务：
资源简介：
Figure S1. Response to lebrikizumab treatment in adolescents naive to targeted therapy and in those with prior targeted-therapy failure at 16 and 24 weeks
创建时间：
2026-01-26
